Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Desipramine × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Endocrine 1

Conditions

Small Cell Lung Carcinoma 1 Neuroendocrine Tumors 1

Interventions

Nivolumab 2 tislelizumab 1 surufatinib 1 pembrolizumab 1 cabozantinib 1 Temozolomide 1 Ipilimumab 1 Desipramine 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01719861 2017-04-17

Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors

Stanford University

Phase 2 Terminated

6 enrolled 12 charts

EndocrineNETThoracic

Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡